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Summary. There is an interest in bioprospecting organisms from the aquatic environment to find novel bioactive compounds with health 
promoting or other functional properties. The aim of this study was to evaluate extracts from  untreated and heat-treated salmon tissues for their 
radical scavenging activities and for their ability to inhibit activity of the proteases angiotensin I-converting enzyme (ACE) and dipeptidyl 
peptidase 4 (DPP-4). In vitro assays were used to detect these activities and the corresponding candidate bioactive compounds were characterized 
by LC-MS/MS.  
Radical scavenging activity was detected in <10kDa extracts of gills, belly flap muscle and skin with EC50 values of 39, 82 and 100 µg/mL, 
respectively. No ACE or DPP-4 inhibiting activity could be detected. LC-MS/MS analysis of dominating compounds in active fractions from size 
exclusion chromatography showed that families of related compounds were found in several fractions from different tissues but most pronounced 
in gills. One family was defined according to content of a specific amino acid sequence (PW). Three families were defined by the m/z value of 
the smallest compound reported in each family (219, 434 and 403). The three latter families did not contain standard unmodified amino acids, 
indicating peptides with modified amino acids or other kinds of molecules. 
Industrial relevance. Bioprospecting in fish tissue traditionally regarded as waste can lead to detection of novel natural bioactive compounds 
including peptides, which could have nutritional, pharmaceutical or other functional value and be used in health and functional foods, thus 
increasing the value adding of secondary marine products. A number of  naturally occurring antimicrobial  peptides have been characterized from 
fish skin and gills, such as piscidins, but these and other fish tissues may contain numerous other compounds with bioactive properties. Such 
compounds could be extracted by the subsection of the fish industry that processes marine secondary products and further developed to 
commercial products. Thus, the identification of novel bioactive compounds could be utilized by the pharmaceutical and biotech industry to 
develop new products. 
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INTRODUCTION 
 
Fish are adapted to living conditions utterly different from land-living organisms. For instance, fish must in general possess an 
eminent bioactive defense to protect them from the high bacterial load in water, and may thus be expected to harbor bioactive 
molecules for this purpose (Harnedy & FitzGerald 2012). Bioprospecting in fish tissues that traditionally has been regarded as 
waste, or has been used for low-value purposes, like animal feed, can lead to detection of novel natural bioactive compounds 
including peptides with health promoting and functional properties.   
A large number of natural antimicrobial peptides (AMPs) are found in invertebrates, and such peptides have also been 
identified in a number of fish species (Rajanbabu & Chen 2011). Some AMP families are unique for fish such as the antimicrobial 
polypeptides piscidins from gills (Corrales et al., 2009, Corrales et al., 2010). Studies have shown that some of these peptides 
also exhibit immunomodulatory and antitumor activity (Rajanbabu & Chen 2011). It is therefore possible that some of these 
peptides are multifunctional and may exhibit other highly relevant bioactivities with health promoting properties eg., oxidative 
stress that can be suppressed by radical scavenging molecules (Katayama & Mine 2007), hypertension that can be reduced by 
angiotensin I-converting enzyme (ACE) inhibiting molecules (Fyhrquist & Saijonmaa 2008) and insulin secretion that can be 
influenced by dipeptidyl peptidase IV (DPP-4) inhibiting molecules (Flatt et al., 2008). The past two decades, the identification 
of possibly bioactive compounds, present in marine secondary products, has been an emerging area of research (Kim and Mendis 
2006). Several investigations have shown that processing leftovers contain significant levels of proteins, cryptides and peptides 
with bio-functional and techno-functional properties.  Peptides derived from marine proteins (cryptides)  have proved to be 
effective against several ailments, such as hypertension (Enari et al. 2008, Gu et al. 2011), osteoporosis (Kanis 2002), 
cardiovascular diseases  (Wergeland et al. 2004), and cancer (Picot et al. 2006). However, like mammals, fish tissue also 
contains, in variable amounts, some peptides or amino acids with antioxidative activity such as the imidazoles anserine, carnosine 
and histidine (Abe et al., 1983; Shirai et al., 1983; Suzuki et al., 1990) and glutathione (Bauchart et al., 2007). Additionally, one 
study has shown that anserine possesses angiotensin converting enzyme (ACE) inhibiting properties (Hou et al., 2003).  
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Recently, Pampanin et al. (2012) compared peptides with known bioactivities, such as ACE inhibition, antioxidative, or 
immunomodulatory activities, with small peptides from herring tissues detected by LC-MS/MS. Based on their sequences, a 
number of herring peptides with potential bioactivities were suggested. None of the peptides appeared to contain modified amino 
acids. However, a review by Harnedy & Fitzgerald (2013) shows salmon and salmon by-products, compared to many other 
marine organisms, have not been subjected to the same extent of bio-prospective multifaceted research activities.  
Furthermore, only few studies have isolated and characterised novel naturally occurring low molecular compounds in fish 
tissue that can exhibit radical scavenging activity or act as inhibitors toward ACE. To our knowledge studies investigating 
compounds from fish tissues with DPP-4 inhibiting properties have not previously been carried out. Farmed salmon is nutritional 
and healthy and has become a popular food worldwide. The market is not satiated yet and the scale of production is still 
increasing. According to FAO FishStat, the global aquaculture annual production of Salmo salar (Linnaeus, 1758) in 2012 was 
approx. 2 million tons. The remaining processing leftovers from salmon production amounting to hundreds of thousand tons per 
annum include trimmings, frames, fins, heads, skin, shells and viscera. These secondary products are normally used for 
production of fish oil, essential fatty acids, fishmeal, fish silage and animal feed, but can also be utilized for production of high-
priced products. The extraction and subsequent exploitation of marine by-products for components with bioactive properties 
represents an excellent strategy for added-value generation. 
The aim of this study is to evaluate radical scavenging activity, ACE and DPP-4 inhibiting activities in extracts from skin, belly 
flap muscle and gills from salmon, and characterize the corresponding candidate bioactive compounds to observed activities.  
 
MATERIALS AND METHODS 
 
Salmon tissues. Gills, skin and belly flap muscle from fresh Atlantic salmon (Salmo salar) (Fig. 1) obtained from a 
commercial fish farm were vacuum packed and stored at - 40°C until use.  
Preparation of tissue extracts with and without heat treatment. Thawed gills, skin and belly flap muscle from salmon were 
cut into small pieces (approx. 0.5x0.5x0.5 cm for gill and belly flap muscle and 0.5x0.5x0.1cm for skin). For each tissue two 
samples were prepared where tissue pieces were mixed with 3 volumes of water (w/v) (e.g. 20 g fish tissue + 60 mL water). One 
sample was boiled in a water bath at 100°C for 10 min. The other sample was not boiled but kept on ice for 10 min. After 
heating, the tissue/water suspensions were homogenized with an ultraturrax T25 (IKA Labortechnich) at 13500 rpm for 5 min on 
ice. The suspensions were centrifuged for 45 min at 21000xg at 4°C. The supernatant was filtered through a 150 mm filter paper 
(Frisenette nr. 201), followed by filtration through 0.45 and 0.20 µm filters (Sartorius) on ice. The obtained filtered extracts were 
kept on ice until ultra filtration.  
Chemicals. 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS), Gly–Pro-p-Nitroanilide, captopril, 1-methyl-L-
tryptophan, 5-methyl-DL-tryptophan, diprotin and protease type XIV from Streptomyces griseus ≥ 3,5 units pr mg (pronase) 
were purchased from Sigma Aldrich (St. Louis, MO, USA). Abz-Gly-Phe(NO2)-Pro was purchased from Bachem AG 
(Bubendorf, Switzerland).  
Preparation of mucosal extract. Mucosal extract from pig intestine was used as enzyme source for DPP-4 and ACE activity. 
Pig intestine was obtained from a Danish landrace/ Yorkshire cross that had been fasted overnight before slaughter and then 
stored at - 20°C. Jejunum (1 m) was filled with 100 mL of 0.1 M Tris-HCl buffer, pH= 8.0 (22˚C) and inverted briefly 5 times. 
The crude extract was filtered through a fine-meshed sieve and centrifuged at 4000xg for 30 minutes at 4˚C. The supernatant was 
saved and 40 mL was dialysed for 24 h at 2˚C in 10 kDa dialysis tubing against 100 x volume of 0.1 M Tris-HCl buffer pH 8. 
Protein content of the recovered dialysed mucosal extract was 7.2 mg/mL as determined with Pierce BCA protein assay (Thermo 
Scientific, Rockford, IL, USA)   using bovine serum albumin (BSA) as standard. The recovered dialysed mucosal extract was 
frozen in aliquots at -20˚C until use.  
Ultrafiltration of extracts. The filtered extracts were fractionated by ultrafiltration with Vivaspin 10 kDa cut off filters 
(Sartorius) at 4000xg at 4°C for 45 min. The filtrates named as <10 kDa extracts were stored at -20°C until use.  
Peptide content. Peptide content in the <10 kDa extracts was measured with the Pierce Modified Lowry Assay (Thermo Fisher 
Scientific, Rockford, IL, USA). The lower peptide content in the fractions obtained from size exclusion chromatography was 
measured with the more sensitive Pierce BCA Protein Assay.  For both methods BSA was used as standard and peptide content is 
expressed as mg protein per mL. 
ABTS●+ radical scavenging activity (modified after Clausen et al., 2009). A volume (50 µl) of <10 kDa extracts or dilutions 
thereof were combined in 96 well microplates with  200 µl of ABTS●+  solution (0.37 mM in 0.1 M borate buffer, pH=8.0), 
which had been prepared from 18.7 mM ABTS and 8.8 mM ammonium persulfate in water that had been incubated overnight at 
room temperature. All dilutions were done in borate buffer. Absorbance was measured at 734 nm in a microplate reader (Biotek, 
Synergy 2). ABTS●+ free radical scavenging activity was defined as decrease in absorbance after 30 min. 50 µl of water was used 
as control for 100% absorbance. 
DPP-4 inhibitory activity (modified after Li-Chan et al., 2012). A volume (50 µl) of <10 kDa extracts or dilutions thereof 
were combined with 50 µl of intestinal mucosal extract (diluted 27 times in 100 mM Tris-HCl buffer pH=8.0) in 96 well 
microplates and prewarmed to 37˚C. All dilutions were done in 0.1 M Tris-HCl buffer, pH 8.0, 25°C. Prewarmed DPP-4 
substrate (200 µl of 2.5 mM Gly-Pro-Nitroanilide, 0.1 M Tris-HCl buffer, pH 8.0, 25°C) was added and absorbance measured at 
405 nm (and 600 nm to correct for light scatter) every two minutes for 20 minutes in a microplate reader (Synergy 2, Biotek) at 
37°C. 50 µl of water was used as control for 100% activity and 2 mM diprotin was used as reference inhibitor. DPP-4 activity 
was calculated as ∆ mOD 405 nm/min as initial rate for the linear part of the curve and scatter subtracted if present. Inhibition 
was calculated as activity in % of activity in control. 
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ACE inhibitory activity (modified after Sentrandreu & Toldra 2006). A volume of 50µl of <10 kDa extracts in 3-fold 
dilution was added to a well in 96 well microplate. Intestinal mucosal extract (50 µl of 10 times diluted extract in 150 mM Tris-
HCl buffer pH 8.3) was added to the wells. Before addition of substrate, the microplate was preincubated at 37˚C for 10 minutes 
in the fluorescence spectrophotometer (Gemini max, Molecular Devices) with automatic mixing. The substrate working solution 
(light sensitive) (0.45 mM Abz-Gly-Phe(NO2)-Pro in 150 mM Tris-HCl buffer pH 8.3, 25°C with 1.125 M NaCl) was also 
incubated at 37˚C for 10 minutes in a water bath. Subsequently, 200 µl of substrate solution was added. 50 µl of water was used 
as control for 100% activity and 0.12 µM captopril was used as reference inhibitor. Fluorescence was measured every minute as 
Relative Fluorescence Units (RFU) after automatic shaking for a total of 40 minutes at λ (excitation) = 355 nm and λ (emission) 
= 405 nm. ACE activity was defined as ∆ RFU per min and inhibition was calculated as activity in % of activity in control. 
 
 
 
Figure 1. Picture of the salmon tissues used for extraction of bioactive compounds. (A) Gill, (B) Skin, ( C) Belly flap muscle 
Experimental design 
 
 
 
Figure 2. Schematic flowchart showing the experimental design of analyzing bioactive compounds in tissues from salmon 
 
Determination of EC50 values. EC50 values were determined by dose-response experiments, where ABTS●+ radical scavenging 
and ACE and DPP-4 inhibitory activity were measured with 3-fold dilutions of extracts. Non-linear regression for estimation of 
EC50 values was performed using sigmoidal dose-response curves with individual Hillslope coefficients (y=min+ (max-
min)/(1+10^(EC50-x)Hillslope) built into Sigmaplot v. 11 graphing and statistics software (Systat software Inc)  
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Size exclusion chromatography (SEC). Compounds in <10 kDa extracts were separated by FPLC (Fast Performance Liquid 
Chromatography) using an Äkta Purifier system with FRAC 950 collector. Undiluted filtrate (200 µl) was injected into a 
SuperdexTM peptide 10/300 GL column (GE Healthcare) using 100 mM ammonium acetate buffer pH 8 with a flow rate at 0.5 
mL/min. Ammonium acetate is a volatile buffer that minimally affects subsequent steps of mass spectrometry.  Compounds were 
detected at 215 nm and 280 nm. Fractions of 1 mL each were collected (35 fractions in total) and stored at -20°C until use. 
Cytochrome c (12.3 kDa), aprotinin (6.5 kDa), Lys5 (659 Da), Gly3 (189 Da), and Gly (75 Da) (Sigma-Aldrich, St. Louis, 
Missouri, USA) were used as molecular weight markers. 
 Pronase treatment of extracts. Pronase (1 mg/mL) dissolved in 100 mM Tris-HCl pH 8 was mixed with <10 kDa extracts in 
the ratio 120 µl to 480 µl (pronase 5 times dilution, Enzyme:Substrate ratio 1:4 (v:v)) in a microcentrifuge tube. Control samples 
without pronase but with water were made the same way. A sample containing only pronase (1 mg/mL) was made to indicate 
elution of pronase and corresponding autolytic peptides, if any. The microcentrifuge tubes were placed in a 37˚C water bath 
overnight (16 hours) and immediately analysed by SEC as described above.  
LCMS and LCMS/MS. Fractions from the size exclusion  chromatography that showed antioxidative capacity were dried in a 
SpeedVac (Thermo Scientific Savant SPD1010) and reconstituted in 50 µl buffer A (5% acetonitrile [ACN] + 0.1% formic acid 
[FA]), vortexed, centrifuged at room temperature at 14,000xg for 10 min and transferred to LC vials. Buffer B was 90% ACN + 
0.1% FA. A nanoHPLC (EASY nLC; Proxeon, Odense, Denmark) was used. The samples were trapped on an EASY reverse 
phase pre-column (2 cm length, ID 100 µm, 5 µm C18 beads) and separated on an EASY reverse phase analytical column (10 cm 
length, ID 75 µm, 3 µm C18 beads). Flow rate was 300 nL/min. The time from mixer to elution was 3 min, corresponding to a 
dead volume of around 900 nL. The components were eluted by a gradient  (0 min 100%A, 0.05 min 99%A, 2 min 90%A, 21 
min 45%A, 23 to 26 min 0%A,  28 min  95%A, 30 min 100%A) into a micrOTOF-QII mass spectrometer (Bruker Daltonik, 
Bremen, Germany) through the standard nanosprayer into the electrospray ion source. Nitrogen was used as nebulizer (pressure 
at 1 bar) and drying gas (5 L/min at 150 °C) in the ion source. Argon 5.0 was used as collision gas, and the collision energy was 
automatically adjusted to the selected m/z values using default options. Infusion of electrospray calibrant solution (Fluka) by a 
syringe pump was used as external calibration for the samples. Additionally, a standard mixture of tryptic peptides made from 
BSA (Agilent) was run for every fifth LC-MS/MS sample, and was used for more detailed external calibration. The MS 
instrument was controlled by instrument-specific software (Compass 1.3 micrOTOF control v2.3), where the acquisition 
parameters were set (positive mode, low mass limit at m/z 50, MS/MS auto in the m/z range 70 to 800, 4 precursor ions with 
absolute intensity > 2000 counts, exclude after 4 spectra, release after 1 min). The data were initially analyzed in the Compass 1.3 
DataAnalysis v4.0 software to generate the compounds and externally calibrate the spectra. The software extracted compounds 
using intensity threshold at 1000, retention time window 1 min, S/N threshold 3, and relative area and intensity thresholds at 3%. 
 
RESULTS AND DISCUSSION  
 
In the last decade a large number of small antimicrobial peptides have been identified in fish tissue like gills, skin and organs 
(Hoang & Kim, 2013). Studies have shown that some of these peptides also can have other bioactive properties like anticancer 
activity (Chang et al., 2011) and immunomodulatory activity (Hsieh et al., 2010). This suggests that salmon tissue could have 
unidentified endogenous peptides or other compounds that possess other bioactive properties apart from antimicrobial activity. 
This is supported by the study by Pampanin et al. (2013), who showed that extracts from herring skin and internal organs 
contained many small peptides with potential bioactive properties. The present study analysed three different tissues from salmon 
for low molecular weight compounds (<10 kDa) with radical scavenging activity and ACE and DPP-4 inhibitory properties based 
on the hypothesis that salmon tissue contains novel bioactive compounds. Extraction of compounds was done in water with heat 
treatment to prevent endogenous proteolysis and also to prevent bacterial growth. However as heat treatment may also affect 
relevant compounds such as peptides, an extraction was also carried out without heat treatment. Analysis with Lowry assay 
showed that boiling did not affect the peptide content in <10 kDa extract from gill compared to extract prepared without boiling 
(Table 1). An increase in the amount of recovered peptides was observed in both belly flap muscle and skin extract after boiling 
(Table 1), which could be due to a more efficient extraction from these tissues.  
 
Table 1. Peptide contents and radical scavenging activity in <10 kDa extracts of different tissues from salmon. Peptide content was measured in 
duplicates by the Lowry method using bovine serum albumin (BSA) as standard, and is given as mg protein/mL. Radical scavenging activities are 
reported as the peptide concentrations that were able to remove 50% of the ABTS●+ radicals (EC50, half maximal effective concentration). EC50 
values were estimated by non-linear regression (sigmoidal dose-response curve) with 95% confidence intervals. 
Treatment Tissue mg protein /mL EC50   (mg/mL) EC50   (mg/mL) 95% 
confidence interval 
Boiling Gills 0.84 3.5 x 10-3 2.9 x 10-3 - 4.2 x 10-3
 Belly flap muscle 0.43 8.1 x 10-3 Not analysed 
 Skin 0.77 1.0 x 10-2 9.8 x 10-3 - 1.1 x 10-3 
No Boiling Gills 0.85 5.2 x 10-3 4.6 x 10-3 - 5.7 x 10-3 
 Belly flap muscle 0.26 8.3 x 10-3 7.7 x 10-3 - 8.8 x 10-3 
 Skin 0.43 1.2 x 10-2 9.9 x 10-3 - 1.6 x 10-2 
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Bioactivities. All <10 kDa extracts showed clear  ABTS●+ radical scavenging activities with 95% decrease in absorbance  at 
734 nm (Fig. 3). Dose-response data from analyses of three-fold dilutions of the extracts are shown in Fig. 3. There were 
relatively small differences between the tissues, with gill extracts apparently giving the lowest EC50 value estimated by non-linear 
regression analysis (Table 1), which may suggest that this extract contained compounds with more potent radical scavenging 
activity than extracts from either belly flap muscle or skin.  
 
 
Figure 3. Concentration dependencies of ABTS●+ radical scavenging activities in extracts (<10 kDa) from salmon tissues. Extracts were from (A) 
boiled tissues (filled symbols) or from (B) control (not boiled) tissues (open symbols). The tissues were gill (●,○); belly flap muscle (■,□ ) and 
skin (▲,∆). The curves were fitted by nonlinear regression – global curve fitting. Absorbance was normalized to 1 based on absorbance of water 
as control. 
 
 
None of the <10 kDa extracts inhibited DPP-4 and ACE activity when compared to water as control (results not shown). This is 
notable as Pampanin et al. (2012) found that extracts of herring skin with PBS buffer contained several small peptides with 
potential bioactivity on the cardiovascular system such as reducing hypertension. 
Size exclusion chromatography. Size exclusion chromatography of <10 kDa extracts showed very different elution profiles of 
compounds from belly flap muscle, gills, and skin, respectively, as detected by absorbance at 215 and 280 nm (Fig. 4), indicating 
different compositions of low molecular weight compounds in these tissues. A common feature for boiled extract from all three 
tissues was that compounds did not elute before 18 mL, which corresponds to the MW of Gly3. This indicated that even though 
extracts were fractionated by 10 kDa cut-off ultrafiltration, the largest compounds eluting were in the range of 400-500 Da 
assuming that there was no extraneous interaction between the compounds and column matrix. Both at 280 nm and 215 nm 
between 3 and 5 peaks eluted after Gly. This indicates that all extracts contained compounds that adsorbed to the column and 
therefore could have an MW larger than Gly. Only control extracts from gills contained compounds that eluted with void volume, 
which suggested a MW larger than 7 kDa. These compounds could have precipitated during boiling as they were not detected in 
the filtrate. Boiling also influenced the profile of belly flap muscle as shown by an increase in compounds eluting between 20 and 
22 ml. In contrast no effect of boiling was observed for skin. 
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Figure 4. Size exclusion chromatography (SuperdexTM peptide 10/300 GL column) of <10 kDa extracts (boiled and not boiled) from three 
different salmon tissues: gills (top row), belly flap muscle (middle row) and skin (bottom row). Designation of peptide standards markers is 
shown on figure “Gill” (top row, left column). Eluting components were detected by absorbance at 215 and 280 nm. 
Test of peptide content in peaks from size exclusion chromatography. A test of peptide content was made by addition of 
pronase to the boiled < 10 kDa extracts and analysed by SEC. Peaks  that were affected by the treatment with pronase indicated 
presence of peptides consisting of standard amino acids.  
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Figure 5. Effect of pronase (Streptomyces griseus protease XIV) on Size exclusion chromatography elution profile of < 10 kDa extracts from 
boiled salmon tissue. (A) Gills, (B) Belly flap muscle, (C) Skin. ― Without pronase; ······ with pronase.  Pronase (1 mg/mL in 100 mM Tris-HCl 
pH 8) was mixed with extract in ratio 1:4 (v:v) and incubated 16 hours before analyses by SEC. 
 
Fig. 5 shows the elution profiles of < 10 kDa extracts from gills, belly flap muscle and skin with and without pronase. Pronase 
eluted as a single peak at 9 mL corresponding to the void volume. In general, the pronase treatment had surprisingly little effect 
on the extracts. The resistance to proteolysis indicated the presence of compounds other than unmodified peptides. The main 
effect of pronase on the gill extract was on a peak eluting at 22 mL, which was reduced considerably, while a peak eluting at 24 
mL correspondingly increased (Fig. 5A). The pronase treatment on belly flap muscle extract (Fig. 3B) mainly resulted in a 
decrease of a major peak eluting at 19 mL. An increase in a peak eluting at 19.5 mL could be a result of cleavage products from 
peptides eluting at 19 mL. Three peaks eluting at 20.5, 22 and 26 mL also decreased after pronase treatment. Interestingly, the 
decrease of these peaks did not result in increase in new peaks eluting later, possibly because pronase destroyed the peptide 
bonds. The effect of pronase treatment on skin extract seemed somewhat smaller than on gill and belly flap muscle extract (Fig. 
5C). As for belly flap muscle extract, a decrease in peaks eluting at 19 and 26 mL was seen.  
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ABTS●+ radical scavenging activity and peptide content in fractions from boiled salmon. Peptide content and radical 
scavenging activities were measured in fractions from the size exclusion chromatographed samples of boiled < 10 kDa extracts 
from salmon gills, belly flap muscle and skin (Fig. 6). There was no ABTS●+ scavenging activity in fractions eluting from 0-
16mL. In the fraction eluting  at 18 mL, a weak ABTS●+  radical scavenging activity  was observed for gills and skin, which 
could be due to peptides in the low molecular weight range (between Gly3 and Lys5). Pampanin et al. (2013) identified small 
peptides in extracts from herring skin that could have antioxidative properties, suggesting that fish skin in general contains small 
peptides with antioxidative properties. However, there is not a full correlation between peptide content and radical scavenging 
activity indicating the presence of inactive peptides or that other types of compounds were contributing to the activity. The 
strongest ABTS●+ radical scavenging activity was detected in fractions eluting between 21 and 22 mL for all three tissues with 
strongest activity in the gill extract, where also the highest peptide content was detected. This is in agreement with the lower EC50 
value for gill extract compared to the two other tissue extracts. These fractions eluted after glycine and suggest the presence of 
compounds with some affinity to the column material. Radical scavenging activity was also detected in fractions eluting at 28 and 
33 mL for gill and skin, respectively, indicating even stronger interaction with the column. Fractions from untreated salmon 
extracts were also analyzed with the ABTS●+ radical scavenging assay, and the activity profiles matched those from boiled 
salmon extract (results not shown).  
 
 
 
Figure 6. Peptide content (A) and ABTS●+ radical scavenging activity (B) in fractions from size exclusion chromatography of <10 kDa extract 
from boiled salmon tissue. (●) Gills,( ○) Belly flap muscle, (+) Skin. Peptide standards markers are shown in A. Peptide content was analysed 
with bicinchoninic acid assay (Pierce BCA Protein Assay) with bovine serum albumin as standard. 
 
LC-MS and MS/MS. The fractions from the boiled samples that showed the highest ABTS●+radical scavenging activity were 
selected for analysis by mass spectrometry. Focus was on the major compounds in the fractions (Fig. 5a, b and c) that gave 
MS/MS spectra of reasonable quality. C18 reverse phase columns were used in the LC-MS analyses. Very hydrophilic 
compounds are not retained on such columns, and will therefore not be detected.   
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Figure 7a. Base peak ion chromatograms from nanoLC reverse phase separation of fractions from salmon gill. The fractions were from size 
exclusion chromatography (SEC) performed on <10 kDa extract from salmon gill, and collected in 1 ml portions at (A) 18 mL (B) 21 mL, (C) 22 
mL, (D) 28 mL, (E) 29 mL (cf. Fig 4), corresponding to the fractions showing the highest ABTS●+  radical scavenging activity.   ― Sample; --- 
Blank; Arrows indicate peaks containing components that have been characterized by MS/MS and are mentioned in text and tables.  
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Figure 7b. Base peak ion chromatograms from nanoLC reverse phase separation of fractions from belly flap muscle. The fractions were from 
size exclusion chromatography (SEC) performed on <10 kDa extract from salmon belly flap muscle, and collected in 1 ml portions at (A): 21 mL, 
(B) 22 mL. (cf. Fig 4), corresponding to the fractions showing the highest ABTS●+  radical scavenging activity.   ― Sample; --- Blank; Arrows 
indicate peaks containing components that have been characterized by MS/MS and are mentioned in text and tables. 
 
 
Figure 7c. Base peak ion chromatograms from nanoLC reverse phase separation of fractions from salmon skin. The fractions were from size 
exclusion chromatography (SEC) performed on <10 kDa extract from salmon skin, and collected in 1 ml portions at 22 mL (cf. Fig 4), 
corresponding to the fraction showing the highest ABTS●+  radical scavenging activity.   ― Sample; --- Blank; Arrow indicate peak containing 
components that have been characterized by MS/MS and are mentioned in text and tables. 
 
The mass spectrometric analyses showed three conspicuous features. First, some compounds were found in several fractions 
and from different tissues. Second, several families of chemically related compounds were evident. In fact, most compounds 
belonged to one or another multimember family, here called the "PW family", "434 family"  "403 family" and "219 family", as 
recognized by similarities of the MS/MS spectra within each family (Tables 2, 3, 4 and 5). The families are named according to a 
specific amino acid sequence (PW) or by the lowest m/z value reported in each family. Third, there were only few compounds 
with standard amino acids as major constituents. No proteolytic treatment was performed on the fractions analyzed by MS and 
endogenous proteases were inactivated by the heat treatment. Thus, the detected compounds were likely small compounds or 
peptides freely present in the tissues, although the boiling procedure may have resulted in heat-induced chemical modifications.  
The only compounds that consisted of identifiable amino acids were found in fraction 21 and to a lesser degree in fraction 22 
from gills. M/z 399 (Fig. 8) could be explained as the peptide PPW (theoretical m/z 399.203, observed m/z 399.202), member of 
the PW family (Table 2). The compound m/z 486 was apparently related to m/z 399 (both having MS/MS fragments at m/z 188, 
205 and 302), although the former had a somewhat poor MS/MS spectrum. The mass difference between 399 and 486 could 
suggest an additional Ser, thus giving the sequence SPPW or PSPW (theoretical m/z 486.235, observed m/z 486.235). Comparing 
with zebra fish sequences (the salmon genome is not yet available), the PPW sequence is found in numerous proteins, but we are 
not aware of any previous reports indicating that it may be present as a free peptide. Also the sequences SPPW or PSPW can be 
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found in several tens of zebra fish proteins. The PPW and SPPW/PSPW could be responsible for part of the radical scavenging 
activity observed in fraction 21 of gill and could represent new antioxidative peptides naturally present in fish tissue.  
 
Table 2.  Two compounds in the PW family and two unrelated compounds detected by reverse phase LC-MS/MS. These compounds were only 
found in <10 kDa extract from salmon gills. 
 
Obs. m/z, charge Rt (min) MS(2) fragments Found in Comments 
399.20, z=1 15.7-15.9 146.06, 159.09, 188.07, 205.10, 302.15 Gills fraction 21 PPW (theoretical m/z 
399.20). PW family. 
486.24, z=1 15.0-15.3 157.10, 188.08, 205.10, 302.15 Gills fraction 21 SPPW or PSPW 
(theoretical m/z 486.24). 
PW family 
417.25, z=1 17.6-17.8 132.08, 141.10, 144.08, 159.09, 170.06, 
227.16, 287.14 
Gills fractions 21 and 22 WVL/I or VWL/I? 
(theoretical m/z 417.25) 
247.06, z=1 19.5-19.6 125.02, 141.08, 143.03, 152.07, 183.04, 
203.07 
Gills fraction 28  
 
Table 3. Compounds in the m/z 434 family detected by reverse phase LC-MS/MS. These compounds were only found in <10 kDa extract from  
salmon gills. 
 
Obs. m/z, charge Rt (min) MS(2) fragments Found in Comments 
434.19, z=1 16.3-16.6 116.02, 129.07, 133.10, 141.07, 142.03, 
144.01, 155.09, 162.02, 167.09, 170.03, 
185.10, 199.07, 233.06 
Gills fraction 18  
436.21, z=1 19 116.02, 129.07, 133.10, 142.03, 144.01, 
157.10, 162.02, 170.03, 187.11, 199.07, 
233.07 
Gills fraction 18  
448.20, z=1 19.5 116.02,127.06, 129.07, 142.03, 144.01, 
155.09, 162.03, 170.03, 173.10, 199.11, 
216.14, 233.06 
Gills fraction 18  
 
Table 4. Compounds in the m/z 403 family detected by reverse phase LC-MS/MS. These compounds were only found in <10 kDa extract from 
salmon gills. 
 
Obs. m/z, charge Rt (min) MS(2) fragments Found in Comments 
403.09, z=3 8.7-8.9 112.05, 119.04, 136.06, 162.07, 176.00, 
193.05, 250.10, 288.05, 306.05, 348.07, 
420.09, 462.08 
Gills fraction 21 Likely the same as the co-
eluting 604; here as (M+3H+)/3 
427.61, z=2 9.4-9.6 112.05, 119.04, 136.06, 152.06, 161.06, 
192.08, 216.09, 290.06, 332.08 
Gills fraction 22  
439.62, z=2 9.8-10.1 119.03, 135.03, 152.06, 161.06, 216.09, 
234.10, 314.07, 33208, 394.10 
Gills fraction 21  
447.62, z=2 9.4-9.7 119.03, 135.04, 136.06, 152.06, 161.06, 
216.09, 232.09, 312.05, 332.08, 348.09 
Gills fraction 21  
451.60, z=2 8.7-9.1 112.05, 119.03, 136.06, 143.04, 152.06, 
163.05, 176.80, 191.04, 250.09, 312.05, 
330.05 
Gills fraction 22  
455.59, z=2 8.4-8.6 112.05, 119.04, 136.06, 152.06, 161.06, 
192.08, 216.09, 290.06, 332.07 
Gills fraction 18 Probably different from 455 in 
fraction 22 
455.59, z=2 9.7-10 119.04, 135.04, 136.06, 152.06, 161.06, 
216.09, 232.08, 332.07, 348.08 
Gills fraction 22 Probably different from 455 in 
fraction 18 
459.60, z=2 8.8-9.0 112.05, 119.04, 135.03, 136.06, 152.06, 
177.00, 193.05, 232.08, 250.10, 312.04, 
330.07, 348.07 
Gills fraction 22  
467.59, z=2 8.5-8.8 112.05, 119.03, 136.06, 139.95, 152.06, 
161.06, 192.08, 216.09, 234.09, 290.06, 
314.07, 332.07 
Gills fraction 18  
475.59, z=2 9.0-9.3 112.05, 119.03, 126.07, 135.02, 136.06, 
152.06, 161.07, 176.99, 192.08, 216.09, 
232.08, 314.06, 332.09 
Gills fraction 18  
604.13, z=2 8.6-9.0 112.06, 136.06, 193.05, 208.07, 226.09, 
232.08, 250.09, 268.10, 288.05, 291.06, 
306.05, 330.06, 348.07, 420.08, 462.11 
Gills fraction 21 Likely the same as the co-
eluting 403; here as (M+2H+)/2 
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Table 5. Compounds in the m/z 219 family detected by reverse phase LC-MS/MS. These compounds were found in all <10 kDa extracts from 
salmon tissues (gills, belly flap muscle and skin).  
 
Obs. m/z, 
charge 
Rt (min) MS(2) fragments Found in Comments 
219.06, z=1 18.5-19.3 128.06, 133.02, 141.01, 154.08, 159.02, 
171.03, 173.05, 183,04, 201.05 
Gills fraction 21, 22, 28, 29 
Belly flap fraction 21, 22 
Skin fraction 22 
M + H+ 
437.11, z=1 18.7-18.9 141.01, 159.02, 201.05, 219.06 Gills fraction 21, 22 
Belly flap fraction 22 
2M + H+ 
261.07, z=1 19.6-19.8 129.07, 133.02, 154.08, 171.04, 173.05, 
183.04, 201.05, 219.06 
Gills fraction 21  
655.08, z=1 18.1-18.4 141.01, 159.02, 201.05, 219.06 Gills fraction 22 3M + H+ 
349.12, z=1 20.4-20.6 159.02, 173.05, 201.05, 219.06, 259.09 Gills fraction 22 
Belly flap fraction 21, 22 
 
293.06, z=1 19.8-20.7 141.02, 159.03, 171.03,173.06, 201.05, 
219.07 
Gills fraction 28, 29  
448.13, z=1 19.9-20.1 165.01, 201.04, 219.06, 243.06 Belly flap fraction 21  
 
 
 
Figure 8. MS/MS spectrum of compound m/z 399.202 from  fraction 21 mL from SEC of gill extract, and its identification as PPW. The MS/MS 
fragments with the suggested chemical structures are also generated from free Trp (corresponding to the y1 fragment; data not shown). The m/z 
values of these fragments from free Trp are also found in the databases Metlin (metlin.scripps.edu) and MassBank (www.massbank.jp), and 
together with the Trp-specific y1 fragment at m/z 205, they are probably indicative of a C-terminal Trp. Wi, immonium ion of Trp; P, proline. The 
small diamond () to the right indicates the m/z value of the intact ion. 
A compound of m/z 417 was found in fractions 21 and 22 from gills (Table 2). MS/MS fragments show a strong peak at 
159.09, potentially fitting with the immonium ion of Trp. The remaining mass of the original ion could fit with presence of Val 
and Leu/Ile. Leu/Ile in C-terminal position would give an y1-ion of 132, which is present. Thus, a tripeptide consisting of Trp, 
Val, and Leu/Ile, is a possibility (WVL/I or VWL/I), but there are still a number of unexplained fragments left. Thus, this 
compound is presently considered as unidentified.  
All other compounds contained mainly units that were not standard amino acids; i.e., modified amino acids, or some other 
kinds of molecules.  
The 434 family was found in fraction 18 from gills (Table 3), with compounds of m/z 434, 436 and 448 (distinct from 448 in 
the 219 family). The three compounds eluted at different positions in the gradient, and contained a number of fragment ions in 
common. Additionally, there was one series of fragments that had the same mass difference as the intact ions (m/z 185, 187, 199, 
respectively). 
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The 403 family was found in fractions 18, 21 and 22 from gills (Table 4), and these compounds tended to elute early in the 
gradient (8 to 11 min). Most analyzed members in this family were doubly charged (in contrast to all compounds mentioned 
above).  The members were characterized by a strong MS/MS fragment at m/z 136.06 (a value close to the immonium ion of 
Tyr), and a number of additional common fragments. However, no other data directly supported the presence of Tyr.  
 
  
Figure 9. MS/MS spectra of representatives in the m/z 219 family. (A) m/z 219. (B) m/z 437. (C) m/z 349. Note the common fragments:  m/z 
219, 201, 159 in all three spectra, m/z 141 in A and B, and m/z 173 in A and C. The small diamond () to the right indicates the m/z value of the 
intact ion. 
The 219 family gave the major chromatographic peak(s) in all shown fractions, except in Fig 5a (fraction 18 from gills). The 
family consisted of compounds with m/z 219, 261, 293, 349, 437, and 655.  These compounds had at least 4 MS/MS fragments in 
common with m/z 219 (Fig. 9 and Table 5). M/z 219, 437 and 655 were co-eluting, and the latter was only found in fractions 
where 219 was very intense. They probably corresponded to the same compound (as M + H+, 2M + H+, and 3M + H+, 
respectively).  Also m/z 448 (fraction 21 from belly flap muscle; note that there was also another compound with m/z 448 as 
indicated below) probably belonged to this family, although it only showed two fragments in common with the remaining family 
(fragments 219 and 201). 
Being the common basis of the most prominent family of compounds found in these experiments, m/z 219 was selected for 
further analyses. The isotopic envelope of the intact compound 219 showed intensities of the second and third peaks of 12.84% 
(mean; range 12.27-13.44%) and 1.17% (mean; range 1.08-1.29%). The chemical composition that most closely approximated 
the mean isotopic distribution was C10H10N4O2 (as neutral compound; theoretical m/z for MH+ is 219.0877; theoretical peak 
intensities of 12.82 and 1.16% as calculated by the NIST08 database software).  
There are some biologically relevant compounds that have theoretical m/z values close to the detected in the range 219.05-
219.07. Potassium adducted glucose (theoretical m/z 219.027) can easily be excluded based on both its hydrophilicity and its 
isotopic envelope distribution. Another candidate could be methylated Trp (theoretical m/z 219.113; chemical composition for 
neutral compound is C12H14N2O2). If so, this could suggest 261 as the acetylated methyl-Trp. The spectra of 1-methyl-L-Trp and 
5-methyl-DL-Trp were therefore investigated. The two methyltrypthophans showed very similar spectra (not shown). Only the 
MS/MS fragment at 173 was common for the methyltryptophans and compound 219. Furthermore, some of the major fragments 
showed a 1 Da difference between compound 219 (see also Fig. 9A) and the methyltryptophans (201 vs 202, 183 vs 184, 159 vs 
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160, 133 vs 132). Theoretical peak intensities for methylated Trp are 14.35 and 1.35% for second and third peak, and observed 
intensities were 13.9 and 1.5%, respectively. Thus, the 219 compound is not methyltryptophan, although some kind of chemical 
relationship cannot be excluded. 
The presence of the 219 compound or its family members in most dominating fractions with radical scavenging activity 
indicate that these compounds contribute in general to the observed radical scavenging activity in the different tissues. Thus, the 
219 compound could be an interesting new natural radical scavenging agent. The 219 compound is further discussed below in the 
section "Database searches". 
Many of the characterized compounds exhibited low fractional masses (the numbers after the decimal point). If the analyzed 
compounds consist of the common elements of organic biomolecules, they must contain several rings and unsaturated bonds, in 
addition to oxygens or phosphorus (sulfur can be excluded based on the isotopic peak distributions). Many bioactive peptides 
contain amino acids that possess ring and unsaturated bonds. Trp can exhibit radical scavenging activity as the indolic group can 
serve as hydrogen donor (Pihlanto, 2006). Saito et al. (2003) studied radical scavenging activity of different combinations of 
tripeptides and found that tripeptides with a Trp at the C-terminus exhibited the highest radical scavenging activity. The presence 
of Trp could also explain that these peptides elute after Gly when fractionated on the size exclusion column. The aromatic amino 
acids Phe, Tyr and Trp have been analysed on the SEC column using the previously described method and all three eluted after 
Gly (results not shown). 
Anserine and carnosine, two modified dipeptides with a methylhistidine moiety possessing antioxidant and ACE inhibiting 
activities (Hou et al. 2003), have previously been detected in fish tissue (Shirai et al 1983, Bauchart et al 2007). In the studied 
fractions, we did not detect anserine or carnosine, or any other compound with a methylhistidine moiety.  
Database searches. Searches in chemical databases might in some cases be of considerable help in identifying unknown 
compounds (Little et al., 2012; Wolf et al., 2010). External calibration with known samples run for every fifth fish sample, gave a 
range of m/z between 219.0580 and 219.0627 (average 219.0600) for the 219 molecule.  
The NIST08 database was searched with the data for m/z 219, but no reasonable hits were found. The compound was then 
analyzed by MetFrag (Wolf et al., 2010), using the three databases KEGG, PubChem and ChemSpider in a range from m/z 
219.050±25 ppm to 219.100±25 ppm in steps of 0.01, and using the 9 peaks indicated in Table 5. MetFrag suggested several 
compounds with theoretical fragments covering 5 to 7 of the observed fragments, but when screened against the isotopic 
distribution, most of the hits could be excluded. Compounds with neutral composition C12H11O2P (e.g., PubChem ID 17841952), 
C11H10N2O3 (e.g., PubChem IDs 4268466, 13290790), and C10H10N4O2 (e.g., PubChem ID 28412031) showed 5 to 6 hits with the 
observed fragments, and reasonable fits with the isotopic contribution. However, none of them appeared as obvious candidates 
for being immediately accepted as the presently observed compound, as some of the major peaks were lacking for all hits. 
The theoretical isotopic peak intensities may depend somewhat on the software used in the calculations (we have used the 
calculator in the NIST08 database software). In principle, the isotopic distribution may slightly change according to food and 
trophic level of the organism (McCutchan et al., 2003; Newsome et al., 2007; Henry et al., 2012), although it would not be 
expected that such changes should be detected by the present type of MS. Still, we have compared observed and theoretical peak 
intensities for some salmon peptides identified in other analyses (Falkenberg et al., in prep). Most of the observed intensities were 
92 to 100% of the theoretical intensities, with a few instances (for the third peak in the isotopic envelope) up to 120% of 
theoretical intensity. Thus, it is possible that the chemical composition with the best calculated fit, C10H10N4O2 for the neutral 
compound, could be a close approximation to the real compound with m/z 219. 
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